Enzon Inc. regulatory update

ENZN received two U.S. patents for its hemoglobin-based oxygen carrier, PEG-hemoglobin. Patent No. 5,478,806 covers tumor radiosensitization with PEG-hemoglobin. Patent No. 5,478,805 covers a method o...